Bilal Kovan

Safety of Fibroblast Activation Protein–Targeted Radionuclide Therapy by a Low-Dose Dosimetric Approach Using 177Lu-FAPI04

Serkan Kuyumcu, Bilal Kovan, Fikret Büyükkaya et al. · Clinical Nuclear Medicine · 2021 · 87 citations

The inferior performance of [68Ga]Ga-FAPI-04 PET/CT as a diagnostic and theranostic biomarker in [177Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors

Duygu Has Şimşek, Yunus Güzel, Dilara Denizmen et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2023 · 12 citations

Y90 selective internal radiation therapy and peptide receptor radionuclide therapy for the treatment of metastatic neuroendocrine tumors: combination or not?

Müge Nur Engin, Zeynep Gözde Özkan, Bilal Kovan et al. · Nuclear Medicine Communications · 2020 · 11 citations

Radiation Safety Guide: General Definitions and Radiation Protection Rules in Nuclear Medicine Applications

Yasemın Parlak, Bağnu Uysal, Fatma Suna Kıraç et al. · Nuclear Medicine Seminars · 2020 · 10 citations · Full text